Finally, it is Bismuth's Time

@inproceedings{Ribaldone2017FinallyII,
  title={Finally, it is Bismuth's Time},
  author={Davide Giuseppe Ribaldone and Giorgio Saracco and Rinaldo Pellicano},
  booktitle={Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association},
  year={2017}
}
In an interesting Turkish retrospective study, conducted between 2012 and 2015, involving 1510 adults, Kekilli et al.[1] tested triple therapy (lansoprazole 30 mg b.i.d., clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d.), bismuth group C (lansoprazole, clarithromycin, amoxicillin, and bismuth subsalicylate 524 mg b.i.d.), and bismuth group M… CONTINUE READING